BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20673502)

  • 1. [Vinorelbine plus oxaliplatin versus vinorelbine plus cisplatin for advanced non-small cell lung cancer: a systematic review].
    Liu X; Ma L; Yang K; Tian J
    Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):112-7. PubMed ID: 20673502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of NO regimen and NP regimen on advanced non-small cell lung cancer: a prospective randomized trial].
    Gao JF; Zhang XH; Wang J; Rao ZG; Zhu YZ; Ou WL; Zhang BC; Du GZ
    Ai Zheng; 2005 Aug; 24(8):990-3. PubMed ID: 16086879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A randomized trial comparing oxaliplatin plus vinorelbine versus cisplatin plus vinorelbine for the treatment of patients with advanced non-small-cell lung cancer].
    Zhang XR; Hou M; Sun JD; Gao JF; Zhu YZ; Peng DW; Zhang YP; Chen J; Yang JL; Liang J; Wang PH; Chu DT
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):743-6. PubMed ID: 16483488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A meta-analysis of platinum plus docetaxel or vinorelbine in the first-line treatment of advanced non-small cell lung cancer].
    Liu T; Wu H; Zhuang X; Lu D; Cai R; Wang W
    Zhongguo Fei Ai Za Zhi; 2014 Apr; 17(4):327-35. PubMed ID: 24758908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial.
    Depierre A; Chastang C; Quoix E; Lebeau B; Blanchon F; Paillot N; Lemarie E; Milleron B; Moro D; Clavier J
    Ann Oncol; 1994 Jan; 5(1):37-42. PubMed ID: 8172790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study.
    Monnet I; de CH; Soulié P; Saltiel-Voisin S; Bekradda M; Saltiel JC; Brain E; Rixe O; Yataghene Y; Misset JL; Cvitkovic E
    Ann Oncol; 2002 Jan; 13(1):103-7. PubMed ID: 11863089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
    Gebbia V; Galetta D; Riccardi F; Gridelli C; Durini E; Borsellino N; Gebbia N; Valdesi M; Caruso M; Valenza R; Pezzella G; Colucci G;
    Lung Cancer; 2002 Aug; 37(2):179-87. PubMed ID: 12140141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
    Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
    J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endostar (rh-endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non-small cell lung cancer: A meta-analysis.
    An J; Lv W
    Thorac Cancer; 2018 May; 9(5):606-612. PubMed ID: 29575575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience.
    Mir O; Alexandre J; Ropert S; Montheil V; Martin I; Durand JP; Goldwasser F
    Anticancer Drugs; 2009 Feb; 20(2):105-8. PubMed ID: 19209026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of aidi injection combination with vinorelbine and cisplatin for advanced non-small-cell lung carcinoma: A systematic review and meta-analysis of 54 randomized controlled trials.
    Xiao Z; Jiang Y; Wang CQ; Hu SS; Huang XR; Chen XF; Huang J; Shan LJ; Tang YH; Wang YH; Gong QH; Feng JH; Xiao X; Li XF
    Pharmacol Res; 2020 Mar; 153():104637. PubMed ID: 31935454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial].
    Zhang ZY; Yu SQ; Miao LY; Huang XY; Zhang XP; Zhu YP; Xia XH; Li DQ
    Zhong Xi Yi Jie He Xue Bao; 2008 Feb; 6(2):134-8. PubMed ID: 18241646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
    Hillner BE; Smith TJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vinorelbine plus cisplatin versus pemetrexed plus cisplatin as first-line treatment of advanced non-squamous non-small-cell lung cancer: cost minimization analysis in 12 European countries.
    Grossi F; Bennouna J; Havel L; Hochmair M; Almodovar T
    Curr Med Res Opin; 2016 Sep; 32(9):1577-84. PubMed ID: 27223813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vinorelbine plus cisplatin in the treatment of advanced non-small cell lung cancer previously treated with taxane-based chemotherapy].
    Zhang W; Cao JN; Yin JL; Hong XN; Xu LG
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):587-9. PubMed ID: 14690569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Randomized study of thalidomide combined with vinorelbine and cisplatin chemotherapy for the treatment of advanced non-small cell lung cancer].
    Gu AQ; Han BH; Zhang XY; Shen J; Qi DJ; Xiong LW; Xin Y; Song YY
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):298-301. PubMed ID: 19615288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of rh-endostatin combined with chemotherapy versus chemotherapy alone for advanced NSCLC: a meta-analysis review].
    Cao D; Ge W; Wang H; Zhang L; Zheng Y; Zhang J
    Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):404-13. PubMed ID: 21569645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Aidi Injection () on overexpression of P-glycoprotein induced by vinorelbine and cisplatin regimen in patients with non-small cell lung cancer.
    Ma JJ; Liu HP
    Chin J Integr Med; 2017 Jul; 23(7):504-509. PubMed ID: 27484766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.